Pro-Dex (PDEX) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pro-Dex (PDEX) has outperformed Utah Medical Products (UTMD) over the past year, gaining 92.9% versus a gain of 26.0%. Over five years, PDEX leads with a +180.2% price change compared with -42.3% for UTMD. Pro-Dex is the larger company by market cap ($201.6 million vs $198.0 million), about 1.0 times the size.
On valuation, Pro-Dex trades at a lower trailing P/E (17.4x vs 20.8x for Utah Medical Products). Utah Medical Products pays a dividend yielding 1.78%, while Pro-Dex does not currently pay one. Utah Medical Products converts more of its revenue into profit, with a net margin of 29.3% versus 17.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PDEX | UTMD |
|---|---|---|
| Share price | $63.00 | $69.49 |
| Market cap | $201.60M | $198.01M |
| 1-day change | -0.77% | -2.07% |
| YTD return | +63.72% | +24.18% |
| 1-year return | +92.90% | +25.98% |
| 5-year return | +180.25% | -42.25% |
| P/E ratio (TTM) | 17.36 | 20.81 |
| Forward P/E | 18.16 | — |
| EPS (TTM) | $3.63 | $3.34 |
| Dividend yield | 0.00% | 1.78% |
| Annual dividend | $0.00 | $1.24 |
| Revenue (latest FY) | $77.55M | $38.52M |
| Revenue growth (YoY) | +16.45% | -5.83% |
| Net income (latest FY) | $13.66M | $11.29M |
| Gross margin | 31.38% | 57.12% |
| Operating margin | 16.75% | 29.60% |
| Net margin | 17.62% | 29.30% |
| 52-week high | $77.00 | $76.89 |
| 52-week low | $32.14 | $53.80 |
| Distance from 52-week high | -18.18% | -9.62% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +26.98% | — |
| Average volume | 54.15K | 33.70K |
| Shares outstanding | 3.20M | 2.85M |
| Employees | 201 | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed UTMD by 66.9 percentage points over the past year.
- Utah Medical Products offers a meaningfully higher dividend yield (1.78% vs 0.00%).
- Utah Medical Products is more profitable, keeping 29.3 cents of every revenue dollar as net income versus 17.6 cents for Pro-Dex.
- Pro-Dex grew revenue faster in its latest fiscal year (+16.45% vs -5.83%).
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
PDEX vs UTMD FAQ
Which is bigger, Pro-Dex or Utah Medical Products?
Pro-Dex (PDEX) is larger, with a market capitalization of $201.60M compared with $198.01M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, PDEX or UTMD?
PDEX returned +92.90% over the past 12 months, compared with +25.98% for UTMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PDEX or UTMD?
PDEX has the lower trailing P/E at 17.4, versus 20.8 for UTMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Pro-Dex or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.78%, while Pro-Dex does not currently pay a regular dividend.
Are Pro-Dex and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.